BetterLife Pharma (BETRF) Exchange Rate Effect (2019 - 2026)
BetterLife Pharma (BETRF) posted Exchange Rate Effect of $2150.6 for Q2 2026, up 298356.04% on a QoQ basis from $0.72 in Q1 2026, and up 352.92% year-over-year from $474.83 in Q2 2025.
Powered by 
Analysis
BetterLife Pharma (BETRF) Exchange Rate Effect (2019 - 2026) Analysis & Trends
BetterLife Pharma has reported Exchange Rate Effect for 8 years, with the latest figure at $2150.6 in Q2 2026.
- On a quarterly basis, Exchange Rate Effect rose 352.92% year-over-year to $2150.6 in Q2 2026; TTM through Apr 2026 was $1835.9, a 481.67% increase from a year earlier, with the FY2026 full-year figure at $3657.4, up 116.47% from the prior year.
- Exchange Rate Effect was $2150.6 for Q2 2026 at BetterLife Pharma, up from $0.72 in the prior quarter.
- The five-year high for Exchange Rate Effect was $11353.4 in Q3 2023, with the low at -$25551.8 in Q4 2022.
- Average Exchange Rate Effect over 5 years is -$5034.9, with a median of -$31.81 recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Exchange Rate Effect sank 818.64% in 2022, then jumped 352.92% in 2026.
- Over 5 years, Exchange Rate Effect stood at -$25551.8 in 2022, then climbed by 16.47% to -$21344.5 in 2023, then surged by 103.2% to $682.49 in 2024, then decreased by 21.62% to $534.92 in 2025, then surged by 302.04% to $2150.6 in 2026.
- The last three Exchange Rate Effect figures came in at $2150.6 (Q2 2026), $0.72 (Q1 2026), and $534.92 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | 315,000.00 |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - | 131.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 2,150.58 |
| Jan 31, 2026 | 0.72 |
| Jul 31, 2025 | 534.92 |
| Apr 30, 2025 | -850.30 |
| Jan 31, 2025 | 0.70 |
| Oct 31, 2024 | 682.49 |
| Jul 31, 2024 | 482.74 |
| Apr 30, 2024 | -21,964.09 |
| Jan 31, 2024 | -31.81 |
| Oct 31, 2023 | -21,344.55 |
| Jul 31, 2023 | 11,353.43 |
| Apr 30, 2023 | -10,017.81 |
| Jan 31, 2023 | 1,757.10 |
| Oct 31, 2022 | -25,551.76 |
| Jul 31, 2022 | -7,326.64 |
| Apr 30, 2022 | -5,258.44 |
| Jan 31, 2022 | -10,211.02 |
| Oct 31, 2021 | 3,580.27 |
| Jul 31, 2021 | -4,463.88 |
| Apr 30, 2021 | 66,550.22 |